Guanfacine

BNF:
Not listed
Status:
Amber
Decision Date:
September 2018
 

Comments

See Shared Care guideline for drugs used in the management of ADHD in children and adults

3rd line option for the treatment of attention- deficit hyperactivity disorder in children aged 5 years and over and young adults

 

Amber Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection and initiation of treatment
  • 3: Requiring short or medium term specialist monitoring of toxicity

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app